Trazodone hydrochloride and Kadcyla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trazodone hydrochloride (trazodone hydrochloride) and Kadcyla (ado-trastuzumab emtansine). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Trazodone hydrochloride and Kadcyla. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Trazodone hydrochloride?

Trazodone hydrochloride has active ingredients of trazodone hydrochloride. It is often used in insomnia. eHealthMe is studying from 23,016 Trazodone hydrochloride users. Check the latest studies of Trazodone hydrochloride.

What is Kadcyla?

Kadcyla has active ingredients of ado-trastuzumab emtansine. eHealthMe is studying from 5,813 Kadcyla users. Check the latest studies of Kadcyla.

On Aug, 11, 2026

44 people who take Trazodone hydrochloride and Kadcyla together, and have interactions are studied.

Trazodone hydrochloride and Kadcyla drug interactions.

What are the common drug interactions of Trazodone Hydrochloride and Kadcyla, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Asthenia (weakness)
General physical health deterioration (weak health status)
Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
Iron deficiency anaemia
Neutropenia (an abnormally low number of neutrophils)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Hypertension (high blood pressure)
Infection

male:

n/a

What are the common drug interactions of Trazodone Hydrochloride and Kadcyla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

White blood cell count decreased
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain)
Nausea (feeling of having an urge to vomit)
Skin fissures (a crack in the skin)
Thrombocytopenia (decrease of platelets in blood)

40-49:

Blood bilirubin increased
Gamma-glutamyltransferase increased
Thrombocytopenia (decrease of platelets in blood)
Aphthous ulcer (mouth ulcer)
Asthenia (weakness)
Diarrhoea
General physical health deterioration (weak health status)
Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
Iron deficiency anaemia
Neutropenia (an abnormally low number of neutrophils)

50-59:

n/a

60+:

Nausea (feeling of having an urge to vomit)
Headache (pain in head)
White blood cell count decreased
Cough
Fatigue (feeling of tiredness)
C-reactive protein increased
Overdose
Restlessness (not able to rest)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Blindness

What are the existing conditions these people have? *

Diarrhea: 31 people, 70.45%
Nausea (feeling of having an urge to vomit): 15 people, 34.09%
Breast Cancer Metastatic: 14 people, 31.82%
Dyspnea (difficult or laboured breathing): 12 people, 27.27%
Abdominal Pain Upper: 10 people, 22.73%
Gastroenteritis Radiation (radiation induced inflammation of stomach and intestine): 10 people, 22.73%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 22.73%
Oedema Peripheral (superficial swelling): 10 people, 22.73%
Mucosal Inflammation (infection of mucous membrane): 10 people, 22.73%
Joint Pain: 10 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Trazodone hydrochloride and Kadcyla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously